drugset / Trial / NCT03554304
Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
RandomizedCrossoverTriple-blindOther
Summary
A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
Timeline
- Start
- 2017-02-09
- Primary completion
- 2017-06-05
- Completion
- 2017-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | WCK 5222 | Unknown | — | Intravenous |
Indications
No indication recorded.